BII
KLDO

Bainco International Investors’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bainco International Investors’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$132K Hold
14,500
– – 0.02% 85
2020
Q3 		$161K Hold
14,500
– – 0.02% 84
2020
Q2 		$108K Sell
14,500
-7,537
-34% -$50.5K 0.02% 78
2020
Q1 		$136K Sell
22,037
-16,500
-43% -$108K 0.02% 86
2019
Q4 		$194K Sell
38,537
-5,700
-13% -$36.2K 0.03% 84
2019
Q3 		$333K Buy
+44,237
New +$384K 0.05% 81

Other funds holding KLDO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bainco International Investors's KLDO Position: Q4 2020 in Review

Bainco International Investors held its Kaleido Biosciences, Inc. Common Stock (KLDO) position steady in Q4 2020 at 14,500 shares worth $132K. The position accounts for 0.02% of the portfolio, ranked #85.

Bainco International Investors first reported a position in KLDO in Q3 2019 and has held it in 6 quarters since. The position peaked at $333K in Q3 2019. 61 funds tracked by Wall St. Rank hold KLDO as of Q4 2020.

  • Bainco International Investors held 14,500 shares of Kaleido Biosciences, Inc. Common Stock worth $132K as of Q4 2020.
  • Bainco International Investors left its Kaleido Biosciences, Inc. Common Stock share count unchanged in Q4 2020.
  • Kaleido Biosciences, Inc. Common Stock made up 0.02% of Bainco International Investors's portfolio in Q4 2020, its #85 holding.
  • Bainco International Investors first reported a position in Kaleido Biosciences, Inc. Common Stock in Q3 2019 and has held it in 6 quarters since.
  • Bainco International Investors's Kaleido Biosciences, Inc. Common Stock position peaked at $333K in Q3 2019.
  • 61 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q4 2020.

Based on Bainco International Investors's 13F filing for Q4 2020, filed 12 Jan 2021.